Omega-3 fatty acids, acute coronary syndrome, and sudden death

Current Cardiovascular Risk Reports

Volumn 2, Issue 2, 2008, Pages 161-166

  Harris, William S ^a   von Schacky, Clemens ^b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51349127005     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-008-0029-9     Document Type: Article

References (50)

1. Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106: 2747-2757.
2. Smith SC Jr, Allen J, Blair SN, et al.: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006, 113: 2363-2372.
3. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al.: Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003, 24: 13-15.
4. van de Werf F, Ardissino D, Betriu A, et al.: Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003, 24: 28-66.
5. Wang C, Harris WS, Chung M, et al.: n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006, 84: 5-17.
6. Albert CM, Campos H, Stampfer MJ, et al.: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346: 1113-1118.
7. Burr ML, Fehily AM, Gilbert JF, et al.: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2: 757-761.
8. Burr ML, Ashfield-Watt PA, Dunstan FD, et al.: Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003, 57: 193-200.
9. Geleijnse JM, Brouwer IA, Feskens EJ: Risks and benefits of omega 3 fats: health benefits of omega 3 fats are in doubt. BMJ 2006, 332: 915-916.
10. Marchioli R, Barzi F, Bomba E, et al.: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105: 1897-1903.
11. Barzi F, Woodward M, Marfisi RM, et al.: Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr 2003, 57: 604-611.
12. Yokoyama M, Origasa H, Matsuzaki M, et al.: Effects of EPA on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369: 1090-1098.
13. Iso H, Kobayashi M, Ishihara J, et al.: Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006, 113: 195-202.
14. Thies F, Garry JM, Yaqoob P, et al.: Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361: 477-485.
15. Harris WS: Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 2007, 55: 217-223.
16. Siscovick DS, Raghunathan TE, King I, et al.: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J Am Med Assoc 1995, 274: 1363-1367.
17. Harris WS, von Schacky C: The Omega-3 Index: a new risk factor for death from coronary heart disease?Prev Med 2004, 39: 212-220.
18. Iso H, Sato S, Folsom AR, et al.: Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. Int J Epidemiol 1989, 18: 374-381.
19. Schacky CV, Harris WS: Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 2006, 73: 310-315.
20. Schrepf R, Limmert T, Claus WP, et al.: Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004, 363: 1441-1442.
21. Christensen JH, Riahi S, Schmidt EB, et al.: n-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators. Europace 2005, 7: 338-344.
22. Leaf A, Albert CM, Josephson M, et al.: Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005, 112: 2762-2768.
23. Brouwer IA, Zock PL, Camm AJ, et al.: Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 2006, 295: 2613-2619.
24. Raitt MH, Connor WE, Morris C, et al.: Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005, 293: 2884-2891.
25. Leaf A, Kang JX, Xiao YF, Billman GE: Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003, 107: 2646-2652.
26. Mozaffarian D, Geelen A, Brouwer IA, et al.: Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005, 112: 1945-1952.
27. O'Keefe JH Jr, Abuissa H, Sastre A, et al.: Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 2006, 97: 1127-1130.
28. Christensen JH, Korup E, Aarøe J, et al.: Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 1997, 79: 1670-1673.
29. Christensen JH, Christensen MS, Dyerberg J, Schmidt EB: Heart rate variability and fatty acid content of blood cell membranes: a dose response study with n-3 fatty acids. Am J Clin Nutr 1999, 70: 331-337.
30. Villa B, Calabresi L, Chiesa G, et al.: Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmacol Res 2002, 45: 475-478.
31. Hamaad A, Kaeng Lee W, Lip GY, MacFadyen RJ: Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients. Cardiovasc Drugs Ther 2006, 20: 359-364.
32. Mozaffarian D, Prineas RJ, Stein PK, Siscovick DS: Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. J Am Coll Cardiol 2006, 48: 478-484.
33. Harris WS, Gonzales M, Laney N, et al.: Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. Am J Cardiol 2006, 98: 1393-1395.
34. Algra A, Tijssen JG, Roelandt JR, et al.: QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991, 83: 1888-1894.
35. Mozaffarian D, Gottdiener JS, Siscovick DS: Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol 2006, 97: 216-222.
36. Dhein S, Michaelis B, Mohr FW: Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids. Naunyn Schmiedebergs Arch Pharmacol 2005, 371: 202-211.
37. Yusuf S, Sleight P, Pogue J, et al.: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342: 145-153.
38. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360: 7-22.
39. Hu FB, Bronner L, Willett WC, et al.: Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002, 287: 1815-1821.
40. Ascherio A, Rimm EB, Stampfer MJ, et al.: Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995, 332: 977-982.
41. Erkkila AT, Lehto S, Pyorala K, Uusitupa MI: n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 2003, 78: 65-71.
42. Rissanen T, Voutilainen S, Nyyssönen K, et al.: Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events. The Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation 2000, 102: 2677-2679.
43. Hallgren CG, Hallmans G, Jansson JH, et al.: Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr 2001, 86: 397-404.
44. Block RC, Harris WS, Reid KJ, et al.: EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2007 [Epub ahead of print].
45. Hino A, Adachi H, Toyomasu K, et al.: Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 2004, 176: 145-149.
46. Hjerkinn EM, Abdelnoor M, Breivik L, et al.: Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil 2006, 13: 325-333.
47. Angerer P, Kothny W, Stork S, von Schacky C: Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. Cardiovasc Res 2002, 54: 183-190.
48. Erkkila AT, Matthan NR, Herrington DM, Lichtenstein AH: Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD. J Lipid Res 2006, 47: 2814-2819.
49. von Schacky C, Angerer P, Kothny W, et al.: The effect of dietary w-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 130: 554-562.
50. Sacks FM, Stone PH, Gibson CM, et al.: Controlled trial of fish oil for regression of human coronary atherosclerosis. J Am Coll Cardiol 1995, 25: 1492-1498.